Related Experiment Video
Updated: Jun 22, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population
Beth Nochowitz1, Nancy L Shapiro, Edith A Nutescu
1Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA.
Background:
Poor adherence to warfarin therapy is a major contributor to subtherapeutic anticoagulation.
Objective:
To determine whether use of a monthly medication organizer, filled at each clinic visit, improves anticoagulation control among warfarin-treated patients.
Methods:
Patients who had a history of nonadherence to warfarin and were attending an inner-city anticoagulation clinic were enrolled in this prospective cohort study and provided with a 28-day medication organizer. Patients were instructed to bring their organizers and warfarin tablets to each anticoagulation clinic visit over the following 3 months. At each visit, the international normalized ratio (INR) was measured, warfarin adherence was assessed, and the organizer was filled with the prescribed warfarin regimen until the next scheduled visit. Data on warfarin adherence and INR values during the 3 months prior to enrollment were collected from medical records and compared with postenrollment data.
Results:
Thirteen patients were enrolled and completed at least one postenrollment clinic visit. Adherence to warfarin therapy improved with use of the medication organizer (mean +/- SD preenrollment 55 +/- 25%, postenrollment 67 +/- 21%; p = 0.06). There was a significant decrease in the proportion of subtherapeutic INR values (60 +/- 25% to 35 +/- 29%; p = 0.04) and a significant improvement in the percent of time spent within the therapeutic INR range (32 +/- 22% to 56 +/- 28%; p = 0.03) after enrollment.
Conclusions:
Use of a monthly medication organizer significantly reduced the percent of subtherapeutic INR values and improved the time spent within the therapeutic anticoagulation range among previously nonadherent patients managed in an inner-city anticoagulation clinic.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Therapeutic Drug Monitoring: Affecting Factors